A 45-year-old woman presents with severe dyspnea, fatigue, and signs of right heart failure (elevated JVP, peripheral edema). Right heart catheterization confirms Pulmonary Arterial Hypertension with a mean pulmonary artery pressure (mPAP) of 48 mm Hg and a pulmonary vascular resistance (PVR) of 8.5 Wood units. Vasoreactivity testing with inhaled nitric oxide is negative. Which regimen represents the preferred initial combination therapy strategy for this patient? (A) High-dose Nifedipine and Sildenafil (B) Endothelin Receptor Antagonist and PDE-5 Inhibitor (C) Prostanoid Monotherapy (D) Soluble Guanylate Cyclase Stimulator and Ambrisentan
Asked in GPSC Physician (Specialist Service), Class-1 2026
Answer under review: our editors are checking this question. Try the other GPSC Prelims previous year questions questions meanwhile.
More GPSC Prelims previous year questions questions
- Which of the following statements are correct regarding the pathogenesis of Rheumatoid Arthritis (RA)? (I) The disease is characterized by chronic inflammation of the synovium, leading to the formation of a destructive pannus. (II) Anti-citrullinated protein antibodies have higher specificity than Rheumatoid Factor (RF) for diagnosing RA. (III) The HLA-DR4 allele, particularly the Shared Epitope is strongly associated with susceptibility and more severe disease. (A) All are correct (B) (I) and (II) only (C) (I) and (III) only (D) (II) and (III) only
- A 50-year-old woman with chronic abdominal pain is diagnosed with Irritable Bowel Syndrome with Constipation (IBS-C). She has failed lifestyle changes, fiber and laxatives. Her pain and bloating are significant. Which novel agent, acting as a guanylate cyclase C agonist is the most appropriate next step in pharmacologic management? (A) Lubiprostone (B) Tegaserod (C) Rifaximin (D) Linaclotide
- Which of the following statements are correct concerning Hemochromatosis (HFE-related): (I) It is an autosomal recessive disorder caused by mutations in the HFE gene. (II) The primary mechanism of iron overload is decreased production of the iron regulatory hormone hepcidin. (III) Classic clinical findings include cirrhosis, diabetes mellitus, and bronze skin pigmentation. (IV) Treatment is primarily with iron chelation therapy. (A) (I), (II) and (III) only (B) (II), (III) and (IV) only (C) (I), (III) and (IV) only (D) All are correct
- A 72-year-old man presents with a 6-month history of progressive gait instability, urinary urgency, and difficulty in concentrating. On examination, he has a wide-based, magnetic gait and his MMSE score is 20/30. MRI shows ventriculomegaly out of proportion to sulcal atrophy and evidence of flow void at the aqueduct. Which prognostic factor is most critical to determine if he will benefit from definitive therapy? (A) CSF β-amyloid and tau levels (B) Evidence of demyelination on MRI (C) Improvement of gait after large-volume lumbar puncture (D) Duration of symptoms
- A 28-year-old cattle rancher presents with recurrent fevers, profuse night sweats, migratory arthralgias, and fatigue lasting several months. Examination reveals mild splenomegaly. Serum agglutination test confirms the diagnosis. What is the most effective therapeutic regimen for this patient?
- Which of the following statements are correct regarding the context of Multiple Sclerosis (MS)? (I) The most common course is Relapsing-Remitting MS. (II) The pathological hallmark is the demyelinating plaque in the central nervous system. (III) Diagnosis requires dissemination in space and dissemination in time as demonstrated by MRI or clinical events. (IV) CSF analysis typically shows oligoclonal bands.
- A 60-year-old man presents with rapidly progressive dementia, ataxia, and myoclonus. EEG shows periodic sharp wave complexes. CSF is positive for 14−3−3 protein. What is the most likely pathological finding on brain biopsy?
- Which of the following statements are correct regarding Familial Hypercholesterolemia (FH)? (I) It is an autosomal dominant disorder caused most often by a defect in the LDL receptor gene. (II) Heterozygous FH patients typically present with elevated LDL-C levels and elevated triglyceride level. (III) Homozygous FH often presents with cardiovascular events in the childhood or early adulthood. (IV) Initial treatment for most FH patients is high-intensity statin therapy, often combined with a PCSK9 inhibitor or ezetimibe.